DYN - dyne-tx.com Revenue Growth Rate YoY (Last Twelve Months)

Public company logo of Dyne Therapeutics, Inc. (DYN)

The year-over-year sales volume growth trajectory for the TTM shows that the metric has reached the level of 0.00. The business efficiency of Dyne Therapeutics, Inc. (DYN) relies on the results of the FORCE platform and regulatory approvals. The brand's high authority in the field of RNA therapeutics is coupled with a lack of current revenue, as future pricing power depends on patents and FDA decisions.

Dyne Corp (DYN) Sales Growth YoY (TTM): for the period 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Dyne Pharma (DYN)

- market value and analyst target forecast:
Summary company analytics:Dyne Therapeutics, Inc.
Manufactured product of Dyne Therapeutics Inc

To isolate fundamental stability from market noise, capital focuses on revenue dynamics over the last four quarters. This metric measures annual sales growth rates, smoothing out short-term fluctuations and revealing the actual vector of operational development. By analyzing year-over-year sales volatility over a rolling 12-month period, an investor assesses the risk of overpaying at the peak of the cycle. For Dyne Therapeutics, Inc. (DYN), this trend confirms the effectiveness of diversifying development within the rare muscle pathology segment.